Blister

Socure Names Christian Woodward as Chief Revenue Officer

Retrieved on: 
Giovedì, Marzo 7, 2024

INCLINE VILLAGE, Nev., March 7, 2024 /PRNewswire/ -- Socure , the leading provider of artificial intelligence for digital identity verification, sanction screening, and fraud prevention, today announced that Christian Woodward has joined as its new Chief Revenue Officer.

Key Points: 
  • INCLINE VILLAGE, Nev., March 7, 2024 /PRNewswire/ -- Socure , the leading provider of artificial intelligence for digital identity verification, sanction screening, and fraud prevention, today announced that Christian Woodward has joined as its new Chief Revenue Officer.
  • Woodward will lead Socure's worldwide go-to-market efforts, growth, solution consulting, technical account management and customer success teams.
  • I look forward to partnering very closely with Christian as we deliver on our goal to make Socure the world's most accurate and inclusive risk and identity verification company."
  • I am thrilled and humbled to join them during this next phase of hypergrowth," said Woodward.

How Cinesteam® Helps Manage Smells From Diabetic Foot

Retrieved on: 
Giovedì, Febbraio 29, 2024

FORT LAUDERDALE, Fla., Feb. 29, 2024 /PRNewswire/ -- Diabetic foot is a common concern for those with diabetes. The condition can lead to chronic wounds that produce highly unpleasant smells. Cinesteam® is a natural-based secondary dressing designed to simply and effectively manage smells like those that come from diabetic foot.

Key Points: 
  • FORT LAUDERDALE, Fla., Feb. 29, 2024 /PRNewswire/ -- Diabetic foot is a common concern for those with diabetes.
  • Cinesteam® is a natural-based secondary dressing designed to simply and effectively manage smells like those that come from diabetic foot.
  • The medical condition comes with many health concerns, one of which is commonly referred to as "diabetic foot."
  • Mayo Clinic reports that as much as 50% of those with diabetes can be affected by diabetic neuropathy, opening the doors for diabetic foot to develop.

UAE MDO PET Films Market to hit $32.6 Million by 2027: Fueled by 58% E-commerce Surge and Booming Pharma Industry: Ken Research

Retrieved on: 
Lunedì, Febbraio 12, 2024

The UAE's population is booming at 1.4% annually, fueling demand for diverse packaging solutions, with MDO PET Films rising as a star player.

Key Points: 
  • The UAE's population is booming at 1.4% annually, fueling demand for diverse packaging solutions, with MDO PET Films rising as a star player.
  • Food and beverage giants are driving the market, accounting for a 45% share, with MDO PET Films offering superior barrier properties to keep food fresh.
  • EcoFlex Films lead the way with environmentally friendly MDO PET Films, a multi-billion dollar market segment.
  • Ken Research's comprehensive report offers an in-depth exploration of the UAE MDO PET Films market, including:
    Detailed segmentation by film type, distribution channel, application, and end-user

UAE MDO PET Films Market to hit $32.6 Million by 2027: Fueled by 58% E-commerce Surge and Booming Pharma Industry: Ken Research

Retrieved on: 
Lunedì, Febbraio 12, 2024

The UAE's population is booming at 1.4% annually, fueling demand for diverse packaging solutions, with MDO PET Films rising as a star player.

Key Points: 
  • The UAE's population is booming at 1.4% annually, fueling demand for diverse packaging solutions, with MDO PET Films rising as a star player.
  • Food and beverage giants are driving the market, accounting for a 45% share, with MDO PET Films offering superior barrier properties to keep food fresh.
  • EcoFlex Films lead the way with environmentally friendly MDO PET Films, a multi-billion dollar market segment.
  • Ken Research's comprehensive report offers an in-depth exploration of the UAE MDO PET Films market, including:
    Detailed segmentation by film type, distribution channel, application, and end-user

Krystal Biotech Announces Publication in the New England Journal of Medicine on the Application of B-VEC to Treat Ocular Complications in Patient with Dystrophic Epidermolysis Bullosa

Retrieved on: 
Giovedì, Febbraio 8, 2024

PITTSBURGH, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, today announced data on the compassionate use of beremagene geperpavec (B-VEC), administered as an eyedrop to treat a patient with dystrophic epidermolysis bullosa (DEB) with cicatrizing conjunctivitis has been published in the New England Journal of Medicine (NEJM). The full manuscript, titled “Ocular Gene Therapy in a Patient with Dystrophic Epidermolysis Bullosa,” can be found in the February 8, 2024 issue of the NEJM.

Key Points: 
  • The full manuscript, titled “Ocular Gene Therapy in a Patient with Dystrophic Epidermolysis Bullosa,” can be found in the February 8, 2024 issue of the NEJM.
  • Over 25% of patients with DEB develop ocular complications such as corneal erosions, abrasions, blistering and scarring that can lead to impaired vision.
  • The NEJM publication describes the first application of B-VEC to treat ocular complications in a patient with DEB under a compassionate use program.
  • If approved, this approach could drastically benefit these patients.”
    A patient presented with severe cicatrizing conjunctivitis secondary to DEB.

Shriners Children's Doctor Alerts Parents of Overlooked Dangers of Microwave Soups and Noodles During National Burn Awareness Week

Retrieved on: 
Lunedì, Febbraio 5, 2024

Dr. David Greenhalgh, Chief of Burns at Shriners Children's Northern California, has spent more than 35 years working with pediatric burn patients.

Key Points: 
  • Dr. David Greenhalgh, Chief of Burns at Shriners Children's Northern California, has spent more than 35 years working with pediatric burn patients.
  • Now, the primary culprit is scalding injuries from simple items people forget are dangerous, such as hot liquids and microwave foods.
  • He says while convincing companies to change their packaging for products is a difficult and lengthy process, parents need to be aware of the dangers.
  • All three Shriners Children's burn care locations across the country are accredited by the American Burn Association (ABA) and the American College of Surgeons (ACS) as verified pediatric burn centers.

Relax'in Naturally Reinforces Mental Health

Retrieved on: 
Mercoledì, Gennaio 31, 2024

FORT LAUDERDALE, Fla., Jan. 31, 2024 /PRNewswire/ -- Mental health has been in the spotlight in recent years. As conditions like anxiety and depression become more common and diagnosable, it's important for consumers to have options to address them based on the severity of each case. With milder mental health concerns, solutions like Relax'in can help naturally restore a sense of peace and balance to everyday life.

Key Points: 
  • With milder mental health concerns, solutions like Relax'in can help naturally restore a sense of peace and balance to everyday life.
  • With mental health concerns on the rise, it's important for consumers to have options.
  • Restoring mental health balance with a natural alternative like Relax'in can also help avoid harmful habits rooted in mental instability, such as excessive alcohol consumption and smoking.
  • This ensures that Relax'in provides genuine, powerful, and natural support for those with mental health concerns.

CORRECTION BY SOURCE: Solta Medical's Thermage(R) FLX and TR-4 Return Pad Receive Registration Certifications in China

Retrieved on: 
Lunedì, Gennaio 22, 2024

[See *Correction above: The TR-4 Return Pad is not approved for use by the U.S. Food & Drug Administration.]

Key Points: 
  • [See *Correction above: The TR-4 Return Pad is not approved for use by the U.S. Food & Drug Administration.]
  • "The approval of Thermage FLX, and the TR-4 return pad, marks a significant milestone for Solta Medical," Thomas J. Appio, Bausch Health Chief Executive Officer, said.
  • "The approval from NMPA means we are able to continue the momentum of the growth of Thermage in China," Jiny Kim, Senior Vice President, Solta Medical, said.
  • Ask your doctor for more information about Thermage FLX and see www.thermage.com for additional details.

What is frostbite, what are the signs and how should we treat it?

Retrieved on: 
Mercoledì, Gennaio 17, 2024

Thankfully, with the right preventative and protective measures, the human body can survive these icy temperatures.

Key Points: 
  • Thankfully, with the right preventative and protective measures, the human body can survive these icy temperatures.
  • Here’s what you need to know about identifying and treating the most common cold injury: frostbite.
  • However, despite our bodies’ inherent temperature controls, without the right protection, we might still be vulnerable to cold weather injuries.
  • For frostbite to occur, exposed body parts need to be subjected to a temperature that is below minus 0.55°C.
  • At this temperature it will take several hours for exposed skin to become frostbitten.
  • For example, temperatures in the -20s can cause frostbite on exposed skin in under 30 minutes.

Who does it affect?

  • However, with the global population beginning to live in harsher environments and an increase in winter and snow sports, this is likely to increase in the general population.
  • Reduced ability to sense the cold also increases the frostbite vulnerability of those who’ve had a stroke or have peripheral nerve damage.
  • The consumption of alcohol also reduces blood pressure, which may also reduce the amount of blood pumped to extremities.

Symptoms

  • Preserving the core body temperature is key to keeping the brain, heart, kidneys and lungs functioning and preventing hypothermia.
  • This cooling brings about tingling and numbness of the exposed areas, and skin flushes red or white as the body frantically tries to rewarm itself.
  • This initial stage is known as frostnip, and, although uncomfortable, leaves no permanent damage to tissues.

Treatment and prevention

  • For frostbite, immediate medical treatment should be sought – sadly the pain of recovery is often far worse than the injury.
  • Rewarming is the process of bringing the affected parts back to functioning body temperature.
  • However, where ice crystals have damaged tissue, blisters are common and the nerves become hypersensitive, causing excruciating pain.


Adam Taylor does not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.

Pharmaceutical Contract Manufacturing Market Size to Hit USD 140 billion by 2030 Say, Roots Analysis

Retrieved on: 
Lunedì, Gennaio 15, 2024

LONDON, Jan. 15, 2024 /PRNewswire/ -- The global pharmaceutical contract manufacturing market is anticipated to be worth USD 90 billion in 2023 and is expected to reach USD 140 billion by 2030. It is estimated to grow at a compounded annual growth rate of 6.5% during the forecast period (2022-2030). 

Key Points: 
  • The global pharmaceutical contract manufacturing market faces challenges in the form of high initial investment costs for equipment and facilities.
  • Commercial segment will dominate the pharmaceutical contract manufacturing market during the forecast period and is anticipated to capture 81% by 2030.
  • Based on the type of end users, the pharmaceutical contract manufacturing market is segmented into small, mid-sized, and large pharmaceutical companies.
  • Asia-Pacific will dominate the pharmaceutical contract manufacturing market during the forecast period and is anticipated to capture 37% of the market share by 2030.